Authored By: Sarah
11 Jul 2024

 Motion Sickness Drugs Market Size to grow by USD 139.5 million between 2024-2028

According to a research report “ Motion Sickness Drugs Market” by Product (Antihistamines, Anticholinergics) Distribution Channel (Offline, Online) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 139.5 million, at a CAGR of  4.37% during the forecast period. The global motion sickness drugs market primarily caters to consumers through the availability of both prescription and over-the-counter (OTC) generic drugs. Anticholinergics and antihistamines are the preferred first-line treatments for mitigating and preventing motion sickness symptoms. Notably, several antihistamines are accessible as OTC medications, making them an ideal choice for pediatric patients. These OTC drugs offer increased accessibility, affordability, and self-medication freedom for patients dealing with minor illnesses, including motion sickness. Anticholinergics and antihistamics are primarily used for preventive measures against motion sickness symptoms rather than for treatment.

Browse market data tables, figures, and in-depth TOC on “Motion Sickness Drugs Market” by Product (Antihistamines, Anticholinergics) Distribution Channel (Offline, Online) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Product, the Antihistamines segment is projected to dominate the market size in 2024

In the motion sickness drugs market, offline channels held the largest market share in 2023, accounting for significant revenue. This dominance can be attributed to several factors, including customer preference for product assurance, authenticity, and verification. Offline retailers also provide convenience, personalization, and personal support, which fuels segment expansion. Brick-and-mortar stores offer several advantages, including ease of production and inventory management, geographical presence, and goods transportation. Market players are investing heavily in offline retail to increase their regional and global market shares, as footfall in these stores remains high. Thus, the offline sector's growth in the motion sickness drugs market is expected to continue during the forecast period.

By Distribution Channel, Offline  segment is expected to hold the largest market size for the year 2024

The Motion Sickness Drugs Market encompasses a range of first-generation antihistamines, including Cinnarizine, promethazine hydrochloride, promethazine teoclate, and meclizine. These drugs possess antihistaminic, antitussive, antipruritic, and antiemetic properties. The antiemetic effect is primarily due to the inhibition of histamine 1 (H1) receptors and muscarinic receptors. Cinnarizine, specifically, is a piperazine derivative that functions as an anti-emetic agent. It takes effect two to three hours post-administration, with a half-life of three to six hours. These drugs share comparable efficacy in treating motion sickness, although comparative trials are absent from the current market landscape.

North America is forecasted to hold the largest market size by region in 2024

The Motion Sickness Drugs Market represents a significant business opportunity, driven by the increasing prevalence of motion sickness and the demand for effective treatments. Key players in this market include GlaxoSmithKline, Boehringer Ingelheim, and Merck. These companies offer various motion sickness drugs, such as scopolamine, dimenhydrinate, and meclizine, to alleviate symptoms. Market growth is expected due to rising travel frequencies and the expanding tourism industry. However, potential side effects and regulatory challenges pose challenges for market expansion.

The Motion Sickness Drugs Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • Amneal Pharmaceuticals Inc.
  • Baxter International Inc.
  • CVS Health Corp.
  • DM Pharma Marketing Pvt. Ltd.
  • GlaxoSmithKline Plc
  • Hylands
  • Lupin Ltd.
  • Merck KGaA
  • Myungmoon Pharm Co. Ltd.
  • Novartis AG
  • Perrigo Co. Plc
  • Prestige Consumer Healthcare Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tivic Health Systems Inc.
  • Viatris Inc.
  • WellSpring Pharmaceutical Corp.
  • Zenomed Healthcare Pvt. Ltd.
  • Zydus Lifesciences Ltd.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

Motion sickness is a common medical condition characterized by discomfort, anxiety, and temporary sensation of dizziness, nausea, and vomiting caused by multi-axial motion or acceleration. The motion sickness drugs market encompasses various treatments, including oral drugs, transdermal drugs, traditional medicines, wearable relief bands, and prescription drugs. Online pharmacies have made these treatments more accessible, allowing travelers and individuals with unmet healthcare needs to purchase motion sickness medications conveniently. Oral drugs, such as meclizine and dimenhydrinate, are commonly used to treat motion sickness. Transdermal drugs, like scopolamine patches, offer a longer-lasting effect. Traditional medicines, such as ginger, have also shown effectiveness in alleviating motion sickness symptoms. Wearable relief bands, like Reliefband and Reliefband Sport, use electrical stimulation to prevent the brain from interpreting motion as nausea-inducing. The demand for motion sickness drugs is high in developed economies, particularly among females, cancer patients, and travelers. The coronavirus pandemic has further increased the need for these medications, as people are traveling less but still experiencing motion sickness through virtual reality experiences. Acetylcholine plays a crucial role in the development of motion sickness, making it a popular target for drug development. However, healthcare systems face challenges in addressing the unmet healthcare needs of those suffering from this condition.

Market Research Overview

Motion sickness is a common medical condition characterized by uncomfortable sensations caused by multi-axial motion, such as traveling by sea or air. Retail pharmacies, drug stores, and online pharmacies are major sources of motion sickness drugs for travelers. Oral drugs like Scopolamine, Prochlorperazine, Meclizine, and Dimenhydrinate, as well as transdermal Scopolamine patches, are popular choices for motion sickness treatment. Traditional medicines and wearable relief bands, such as Reliefband and Reliefband Sport, also offer relief. The demand for motion sickness drugs is high in developed economies, with prescription drugs being the preferred choice for some. In Saint Maarten and the Virgin Islands, for instance, Scopolamine and other prescription drugs are commonly used. However, the coronavirus pandemic has led to increased reliance on online providers and hospital pharmacies for medication. Motion sickness drugs belong to the anticholinergic and antihistaminic drug classes. Symptoms of motion sickness include nausea, vomiting, sweating, belching, increased salivation, and discomfort. Children, pregnant women, and cancer patients are particularly vulnerable. Anxiety and discomfort can exacerbate symptoms. Virtual reality and other forms of acceleration can also trigger motion sickness. Anticholinergic drugs like Scopolamine and Hyoscine block the action of Acetylcholine, while antihistaminic drugs like Meclizine and Diphenhydramine block the action of histamine. Pharmacological therapies offer temporary relief from motion sickness symptoms. However, there are unmet healthcare needs, particularly for those who cannot take oral medication or wear relief bands. New innovations, such as wearable devices and personalized medicine, are expected to address these needs in the future.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio